CAI
Caris Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.07
−0.99%Forward multiples
Based on analyst estimates
- P/E forward
- 97.78x
- P/E 2026E
- 198.31x
- P/E 2027E
- 69.74x
- P/E 2028E
- 45.24x
- P/S forward
- 6.37x
Trailing multiples
Trailing twelve months
- P/E TTM
- 67.41x
- PEG TTM
- —
- Price / book
- 11.97x
- Price / sales
- 7.16x
- Price / cash flow
- 35.17x
Enterprise value
- Enterprise value
- $6.7B
- EV / sales
- 6.81x
- EV / EBITDA
- 39.05x
- EV / EBIT
- 44.00x
- Market cap
- $7.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026